Governance
The Groupement d’intérêt public (GIP)
Genopole is a Groupement d’intérêt public (GIP), a form of public-private partnership for missions of public interest. It functions thanks to the steadfast commitment of its 12 members. Genopole is built upon a solid foundation of decision-making bodies and scientific strategy committees that empower its ability to successfully carry out its missions.
The biocluster benefits from the unwavering support of public institutions, notably the French State and the Île-de-France Regional Council. These precious partners provide consequential funding, which enables investments in and the operation of the shared-use technological platforms, and, in turn, innovation and cutting-edge research.
GIP Genopole General Meeting
The General Meeting is composed of representatives from each member institution (see page 47). It is the GIP's administrative body and makes all the main decisions concerning it, such as its strategic orientations, annual activities program and budget. The General Meeting carries out elections for the presidential and vice-presidential posts and also deliberates nominations to the Committee for Science, Innovation and Industry (CSII).
Committee for Science, Innovation and Industry
The Committee for Science, Innovation and Industry (CSII) is presided by Emmanuelle Quilès and composed of qualified persons with particular competencies in Genopole's fields of activity. Its members are approved by the General Meeting. The role of the CSII is to provide the General Meeting with opinions and recommendations on the scientific and industrial orientations of GIP Genopole. A seat on the CSII is accorded intuiti personæ; the members act in strict independence of their affiliations.
A motivated team
GIP Genopole benefits from multidisciplinary teams committed to creating a fertile environment for research and innovation.
Cultivate ties between public and private research.
Our missions
Whether focused on administrative management, research and business, infrastructures and platforms, international affairs or communication, the GIP Genopole teams are all driven by a shared passion: bring progress to life sciences and enable innovation. With their commitment, energy and renowned know-how, these teams have made that passion an objective to be reached via their actions to accompany and develop the biocluster's laboratories, start-ups and businesses.
Genopole's scientific committee
The scientific committee was created in 2023 and the GIP continued its work in 2024, including that of its primary objective of enabling a dialog between the biocluster's research units. Composed of representatives from all of the laboratories, the committee continues to play a key role by responding proactively to the needs of public laboratories and private entities. It works to create durable synergies while continuously adapting and enriching the GIP's initiatives. Through the expertise of its members, the committee guides the thought process toward a scientific repositioning that is both strategic and innovative.
See the Genopole's GIP team
Accelerate the growth and development of biotechs and strengthen their presence within the territory.